Trial Profile
Comparison Between Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome Patients
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary) ; Neomycin
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 11 Mar 2013 New trial record